Literature DB >> 23534428

Quantification of the sixth DNA base 5-hydroxymethylcytosine in colorectal cancer tissue and C-26 cell line.

Liang-Tao Zhang1, Li-Jian Zhang, Jun-Jie Zhang, Xiao-Xia Ye, Ai-Mei Xie, Li-Yu Chen, Jing X Kang, Chun Cai.   

Abstract

BACKGROUND: DNA methylation at the five position of cytosine is well recognized as an important epigenetic modification in human health and disease. Recent evidences demonstrated that 5-methylcytosine (5-mC) by the TET family of enzymes can be converted to 5-hydroxymethylcytosine (5-hmC). Here, we use an ultrasensitive and accurate isotope-based LC-MS/MS method to precisely determine the levels of 5-hmC and 5-mC in colorectal cancer and the C-26 colon adenocarcinoma cell line.
RESULTS: Our data showed that 5-hmC content is significantly reduced (approximately sixfold) in colorectal cancer as compared with adjacent normal tissue. Similarly, the ratio of 5-hmC to 5-mC dropped from 0.054 ± 0.005 in normal tissues, to 0.011 ± 0.002 in cancer.
CONCLUSION: The analysis of 5-hmC levels and the ratio of 5-hmC:5-mC during tumor progression might provide insight into the role of this modification in cellular immortalization and transformation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23534428     DOI: 10.4155/bio.13.28

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  11 in total

1.  Polymerization retardation isothermal amplification (PRIA): a strategy enables sensitively quantify genome-wide 5-methylcytosine oxides rapidly on handy instruments with nanoscale sample input.

Authors:  Danping Chen; Yang Wang; Mingming Mo; Junjie Zhang; Yanfei Zhang; Yuzhi Xu; Si-Yang Liu; Jun Chen; Yingjun Ma; Li Zhang; Zong Dai; Chun Cai; Xiaoyong Zou
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

Review 2.  Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host.

Authors:  Winston Timp; Andrew P Feinberg
Journal:  Nat Rev Cancer       Date:  2013-06-13       Impact factor: 60.716

3.  Identification of a melanoma susceptibility locus and somatic mutation in TET2.

Authors:  Fengju Song; Christopher I Amos; Jeffrey E Lee; Christine G Lian; Shenying Fang; Hongliang Liu; Stuart MacGregor; Mark M Iles; Matthew H Law; Neal I Lindeman; Grant W Montgomery; David L Duffy; Anne E Cust; Mark A Jenkins; David C Whiteman; Richard F Kefford; Graham G Giles; Bruce K Armstrong; Joanne F Aitken; John L Hopper; Kevin M Brown; Nicholas G Martin; Graham J Mann; D Timothy Bishop; Julia A Newton Bishop; Peter Kraft; Abrar A Qureshi; Peter A Kanetsky; Nicholas K Hayward; David J Hunter; Qingyi Wei; Jiali Han
Journal:  Carcinogenesis       Date:  2014-06-30       Impact factor: 4.944

4.  5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer.

Authors:  Santiago Uribe-Lewis; Rory Stark; Thomas Carroll; Mark J Dunning; Martin Bachman; Yoko Ito; Lovorka Stojic; Silvia Halim; Sarah L Vowler; Andy G Lynch; Benjamin Delatte; Eric J de Bony; Laurence Colin; Matthieu Defrance; Felix Krueger; Ana-Luisa Silva; Rogier Ten Hoopen; Ashraf Ek Ibrahim; François Fuks; Adele Murrell
Journal:  Genome Biol       Date:  2015-04-01       Impact factor: 13.583

Review 5.  Multiple Functions of Ten-eleven Translocation 1 during Tumorigenesis.

Authors:  Yi-Ping Tian; Yi-Min Zhu; Xiao-Hui Sun; Mao-De Lai
Journal:  Chin Med J (Engl)       Date:  2016-07-20       Impact factor: 2.628

6.  Epigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer.

Authors:  Hanyang Hu; Maoguo Shu; Lin He; Xueyuan Yu; Xiangyu Liu; Yalin Lu; Yinghong Chen; Xiaoping Miao; Xiaohua Chen
Journal:  Br J Cancer       Date:  2017-01-31       Impact factor: 7.640

7.  DNA Methylation and Hydroxymethylation in Primary Colon Cancer and Synchronous Hepatic Metastasis.

Authors:  Silvia Udali; Domenica De Santis; Andrea Ruzzenente; Sara Moruzzi; Filippo Mazzi; Greta Beschin; Stephanie A Tammen; Tommaso Campagnaro; Patrizia Pattini; Oliviero Olivieri; Alfredo Guglielmi; Sang-Woon Choi; Simonetta Friso
Journal:  Front Genet       Date:  2018-01-09       Impact factor: 4.599

8.  ApcMin/+ tumours and normal mouse small intestines show linear metabolite concentration and DNA cytosine hydroxymethylation gradients from pylorus to colon.

Authors:  Basetti Madhu; Santiago Uribe-Lewis; Martin Bachman; Adele Murrell; John R Griffiths
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

9.  5-hydroxymethylcytosine and gene activity in mouse intestinal differentiation.

Authors:  Santiago Uribe-Lewis; Thomas Carroll; Suraj Menon; Anna Nicholson; Piotr J Manasterski; Douglas J Winton; Simon J A Buczacki; Adele Murrell
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

10.  5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.

Authors:  ZeWen Xiao; Wendy Wu; Chunlong Wu; Man Li; Fuming Sun; Lu Zheng; Gaojing Liu; Xiaoling Li; Zhiyuan Yun; Jiebing Tang; Yang Yu; Shengnan Luo; Wenji Sun; Xiaohong Feng; Qian Cheng; Xue Tao; Shuangxiu Wu; Ji Tao
Journal:  Mol Oncol       Date:  2020-11-14       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.